School of Medicine Publications and Presentations
Phosphodiesterase Inhibitors in Cerebrovascular Perfusion and Pulsatility
Document Type
Editorial
Publication Date
7-4-2024
Abstract
Cerebral small vessel disease are microvascular pathological lesions frequently observed on brain magnetic resonance imaging scans of elderly individuals.1 Current strategies to prevent and treat cerebral small vessel disease include addressing modifiable risk factors such as high blood pressure. Epidemiological data and clinical trials have demonstrated the benefits of treating blood pressure to prevent and reduce the progression of cerebral small vessel disease, especially white matter hyperintensities.2,3 However, therapy targeting mechanisms involved in cerebral small vessel disease is needed as individuals with treated and controlled hypertension still experience progression of white matter hyperintensities.4,5
Recommended Citation
Melgarejo, J. D. (2024). Phosphodiesterase Inhibitors in Cerebrovascular Perfusion and Pulsatility. Circulation Research, 135(2), 332-334. https://doi.org/10.1161/CIRCRESAHA.124.324954
Publication Title
Circulation Research
DOI
https://doi.org/10.1161/CIRCRESAHA.124.324954
Academic Level
faculty
Mentor/PI Department
Neuroscience
Comments
© 2024 American Heart Association, Inc.